Article PDF
References
Cohn JN : Introduction to surrogate markers. Circulation 2004; 109 ( 25 Suppl 1): IV20–IV21.
Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA : Surrogate markers for cardiovascular disease: functional markers. Circulation 2004; 109 ( 25 Suppl 1): IV31–IV46.
Oliver JJ, Webb DJ : Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003; 23: 554–566.
Yamashina A, Tomiyama H, Takeda K, et al: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359–364.
Naka KK, Tweddel AC, Doshi SN, Goodfellow J, Henderson AH : Flow-mediated changes in pulse wave velocity: a new clinical measure of endothelial function. Eur Heart J 2006; 27: 302–309.
Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K : Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35: 898–903.
Laurent S, Boutouyrie P, Asmar R, et al: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236–1241.
Hillege HL, Fidler V, Diercks GF, et al: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777–1782.
Makino H, Nakamura Y, Wada J : Remission and regression of diabetic nephropathy. Hypertens Res 2003; 26: 515–519.
Arnlov J, Evans JC, Meigs JB, et al: Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969–975.
Haraldsson B, Sorensson J : Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier. News Physiol Sci 2004; 19: 7–10.
Camici M : Renal glomerular permselectivity and vascular endothelium. Biomed Pharmacother 2005; 59 ( 1–2): 30–37.
Bakris G : Proteinuria: a link to understanding changes in vascular compliance? Hypertension 2005; 46: 473–474.
Stehouwer CD, Henry RM, Dekker JM, Nijpels G, Heine RJ, Bouter LM : Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction—the Hoorn Study. Kidney Int Suppl 2004; 92: S42–S44.
Pedrinelli R, Giampietro O, Carmassi F, et al: Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14–18.
Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ : Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319–323.
Kohara K, Tabara Y, Tachibana R, Nakura J, Miki T : Microalbuminuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J-SHIPP) study. Hypertens Res 2004; 27: 471–477.
Munakata M, Nunokawa T, Yoshinaga K, Toyota T, J-TOPP Sutdy Group: Brachial-ankle pulse wave velocity is an independent risk factor for microalbuminuria in patients with essential hypertension—a Japanese Trial on the Prognostic Implication of Pulse Wave Velocity (J-TOPP). Hypertens Res 2006; 29: 515–521.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakamura, Y., Makino, H. Brachial-Ankle Pulse Wave Velocity and Microalbuminuria. Hypertens Res 29, 469–470 (2006). https://doi.org/10.1291/hypres.29.469
Received:
Issue Date:
DOI: https://doi.org/10.1291/hypres.29.469